Nolato AB (publ) (STO:NOLA.B)
Sweden · Delayed Price · Currency is SEK 51.50
+0.20 (0.39%)
Nov 4, 2026, 5:29 PM CET
Nolato AB Market Cap
Nolato AB has a market cap or net worth of 13.87 billion as of November 4, 2026. It is the 8,129th most valuable company in the world and the 110th biggest in Sweden. Its market cap has decreased by 16.73% in one year.
Market Cap
13.87B
Enterprise Value
15.67B
Revenue
9.58B
Global Rank
Country Rank
#110 Sweden
PE Ratio
20.61
ChartMarket Cap Chart
Since December 6, 1996, Nolato AB's market cap has increased from 660.32M to 13.87B, an increase of 2,000.96%. That is a compound annual growth rate of 10.71%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 4, 2026 | 13.87B | -16.67% |
| Dec 30, 2025 | 16.65B | 14.02% |
| Dec 30, 2024 | 14.60B | 2.46% |
| Dec 29, 2023 | 14.25B | -3.20% |
| Dec 30, 2022 | 14.72B | -49.35% |
| Dec 30, 2021 | 29.07B | 30.63% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Getinge AB | 74.17B |
| Sectra AB | 62.54B |
| Elekta AB | 23.19B |
| Vitrolife AB | 15.29B |
| MedCap AB | 8.26B |
| Xvivo Perfusion AB | 6.14B |
| CellaVision AB | 4.56B |
| BICO Group AB | 1.66B |